Luc Mainville, Interim Chief Executive Officer at Acerus Pharmaceuticals, holds 875.00K shares in LSL Pharma Group Inc (Ticker: TSE:LSL), holds 5.02M shares in ChitogenX (Ticker: CHNXF), holds 3.04M shares in Valeo Pharma (Ticker: VPHIF). Most recently, Luc Mainville Bought ― shares of LSL Pharma Group Inc on Mar 20, 2024 for an estimated value of 350.00K.